⌘K

Login Start Free

Home/Filings/4/0001415889-22-000186

4//SEC Filing

Amin Naseem 4

Accession 0001415889-22-000186

CIK 0001600132other

View on SEC.gov Company Profile

Filed

Jan 3, 7:00 PM ET

Accepted

Jan 4, 4:10 PM ET

Size

6.7 KB

Accession

0001415889-22-000186

Insider Transaction Report

Form 4

Period: 2021-12-31

Bellerophon Therapeutics, Inc.BLPH

Director

Transactions

Award
Stock Options (right to buy)
2021-12-31$3.10/sh+8,671$26,880→ 23,809 total
Exercise: $3.10From: 2022-12-31Exp: 2031-12-31→ Common Stock (8,671 underlying)
Award
Common Stock
2021-12-31+39,032→ 160,287 total

Footnotes (1)

[F1]RSAs fully vested on grant date.

Documents

1 file

4
form4-01042022_040102.xmlPrimary

Issuer

Bellerophon Therapeutics, Inc.

CIK 0001600132

Entity typeother

Related Parties

1

filerCIK 0001646754

Filing Metadata

Form type: 4
Filed: Jan 3, 7:00 PM ET
Accepted: Jan 4, 4:10 PM ET
Size: 6.7 KB

View on SEC.gov